SCHEMBL17208643

SCHEMBL17208643

Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1NCc1cnc(NC(=O)C2CC2)cn1

nearest known ligand 0.67

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ RAD52 P43351 1/20 0.67
▸ BRAF P15056 15/20 0.65
▸ EGFR P00533 13/20 0.65
▸ ABL1 P00519 4/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19986863 0.92 RAD52 (0.71) RAD52BRAFEGFRABL1
SCHEMBL17208642 0.92 RAD52 (0.79) RAD52ABL1
SCHEMBL2226738 0.84 RAD52 (0.82) RAD52BRAFEGFR
SCHEMBL16588513 0.83 RAD52 (0.71) RAD52BRAFEGFRABL1
SCHEMBL22549122 0.83 ABL1 (0.71) ABL1
SCHEMBL19986849 0.83 RAD52 (0.81) RAD52
SCHEMBL17208720 0.82 RAD52 (0.95) RAD52
SCHEMBL17208696 0.82 RAD52 (0.80) RAD52
SCHEMBL17208738 0.82 RAD52 (0.71) RAD52BRAFEGFR
SCHEMBL22457642 0.81 RAD52 (0.78) RAD52

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2937345-B1 TYPE II RAF KINASE INHIBITORS DANA FARBER CANCER INST INC (US) 2018-03-21 — — EP disclosed
EP-2937345-A2 Type II raf kinase inhibitors Dana-Farber Cancer Institute, Inc. (US) 2015-10-28 — — EP disclosed
Send feedback